A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women Original paper
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read MoreI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
-
Women’s Health
Women’s Health
Women’s health, a vital aspect of medical science, encompasses various conditions unique to women’s physiological makeup. Historically, women were often excluded from clinical research, leading to a gap in understanding the intricacies of women’s health needs. However, recent advancements have highlighted the significant role that the microbiome plays in these conditions, offering new insights and potential therapies. MicrobiomeSignatures.com is at the forefront of exploring the microbiome signature of each of these conditions to unravel the etiology of these diseases and develop targeted microbiome therapies.
-
Divine Aleru
Read More
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read More
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Divine Aleru
What was studied?
The study investigated the relationship between bacterial vaginosis (BV), high-risk human papillomavirus (HR-HPV) infection, and cervical intraepithelial neoplasia (CIN) in Chinese women. Researchers aimed to assess the vaginal microbiota diversity and composition in relation to these infections, utilizing 16S rRNA gene sequencing to explore potential biomarkers and risk factors.
Who was studied?
The study involved 624 participants, of which 423 provided viable samples of vaginal secretions. Participants were categorized into HPV-negative and HPV-positive groups, and further subgrouped based on their BV and CIN statuses. The analysis focused on women aged 25 to 65 years who were not undergoing menstruation or pregnancy and had not been treated for certain infections like vulvovaginal candidiasis.
Most important findings
The study found that women with HR-HPV and BV co-infection showed a more complex vaginal microbiota composition. BV and HR-HPV infections were identified as risk factors for CIN. The microbiota diversity, as measured by the Shannon and Chao1 indices, was significantly higher in women with BV and HPV co-infection. Notably, Lactobacillus iners was enriched in the HPV-positive group, suggesting its potential role in maintaining vaginal dysbiosis and influencing HPV persistence. Additionally, the study highlighted that BV could facilitate HR-HPV infection and contribute to CIN progression.
Key implications
The study emphasizes the significance of vaginal microbiota in understanding the pathogenesis of cervical dysplasia. The findings suggest that monitoring BV and HR-HPV infection could serve as valuable tools for early detection and prevention of CIN. The enrichment of Lactobacillus iners under HPV infection conditions indicates its potential as a biomarker for cervical cancer risk, pointing to the need for further research into microbial therapies to manage HPV-related CIN.
Bacterial Vaginosis
Bacterial vaginosis (BV) is caused by an imbalance in the vaginal microbiota, where the typically dominant Lactobacillus species are significantly reduced, leading to an overgrowth of anaerobic and facultative bacteria.